Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-27

Clinical Trial Update: Pentoxifylline in Children With Malaria [Phase 2]

View source ↗

Summary

A Phase 2 trial of pentoxifylline in children with malaria (Plasmodium falciparum) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria | Phase 2 | Status: TERMINATED